-
2008
28 August 2008: Announcement no. 2, 2008: Zealand Pharma today announced that Dr. David H...
-
Product Pipeline
Zealand's Pipeline comprises 1 compound in phase III, 2 compounds in phase II, 3 compounds ...
2005
4 December 2005:
Stock Exchange Announcement no. 2: Zealand Pharma withdraws IPO24
24 November 2005:
Stock Exchange Announcement no. 1: Zealand Pharma publishes offering memorandum in connection with its listing on the Copenhagen Stock Exchange
11 November 2005:
Zealand Pharma appoints Business Development Officer
12 September 2005:
Zealand Pharma appoints new officer to lead drug development
29 August 2005:
Zealand Pharma completes second stage of its international €26 (USD34) million financing
25 April 2005:
Zealand Pharma appoints new Chief Financial Officer
4 March 2005:
Zealand Pharma enters into expanded collaboration agreement with Wyeth Pharmaceutical
3 March 2005:
Sanofi-Aventis finalize phase IIa clinical study with GLP-1 agonist for type 2 diabetes licensed from Zealand Pharma
21 February 2005:
Zealand Pharma completes first stage of its international €26 (USD34) million financing
10 January 2005:
Zealand Pharma raises € 13,3 million (USD 18 million) in new financing
